ANGELICA: Adherence to Cied Implantation Guidelines and Cardiac Rehabilitation

Sponsor
Istituti Clinici Scientifici Maugeri SpA (Other)
Overall Status
Recruiting
CT.gov ID
NCT05764109
Collaborator
(none)
480
1
68.5
7

Study Details

Study Description

Brief Summary

There are limited data on how the guideline indications for ICD implantation are applied in clinical practice across Europe. Moreover, the impact of "time-dependence" of some indications to implantation on the guidelines adherence is still unknown.

Objective of the present observational study is the evaluation of the adherence to the scientific guidelines in patients with a time-dependent indication to ICD/CRT-D implantation admitted to an in-hospital cardiac rehabilitation program.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    Current guidelines recommend ICD implantation in patients at high risk of sudden cardiac death with either ischemic or non-ischemic heart disease. However, implantation rate of cardiac implantable electrical devices (CIED), especially ICD, CRT and CRT-D, is lower than expected and do not reflect guideline indications.

    Several factors may justify the differences in ICD implantation rates across Europe and the gap between daily clinical practice and guidelines: economic restrictions, poor guidelines awareness, especially among referring cardiologists and general practitioners, and different guidelines adherence. The impact of "time-dependence" of some indications to CIED implantation on the guidelines adherence is still unknown.

    Objective of the present observational study will be the evaluation of the adherence to the scientific guidelines in patients with a time-dependent indication to ICD/CRT-D implantation admitted to an in-hospital cardiac rehabilitation program.

    This is a prospective, multicenter, observational study performed in 6 cardiac rehabilitation facilities.

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    480 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    AdhereNce to Cied Implantation GuidELInes: Cardiac rehAbilitation as a Window on Time-dependent Indications: an Observational Prospective Study (ANGELICA).
    Actual Study Start Date :
    Sep 15, 2019
    Anticipated Primary Completion Date :
    Dec 1, 2023
    Anticipated Study Completion Date :
    Jun 1, 2025

    Outcome Measures

    Primary Outcome Measures

    1. Rate of LVEF assessment [3 months]

      The evaluation of the rate of patients who will perform an echocardiography for LVEF assessment at the end of the time-window as suggested by the guidelines

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 90 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Admission to an in-hospital cardiac rehabilitation program because of a recent index event;

    • Provision of signed and dated informed consent form;

    • Age ≥ 18 years.

    • NYHA II-III class at the admittance in the cardiac rehabilitation facility;

    • LVEF ≤ 40% at echocardiography at the admittance in the cardiac rehabilitation facility;

    • Presence of a time-dependent indication to an ICD/CRT-D implantation:

    • <3 month of optimal medical therapy;

    • <40 days from the index myocardial infarction in patients with acute coronary syndrome;

    • 3 months from the revascularization procedure in patients with surgery;

    • <3 months in patients with a de-novo heart failure episode of no ischemic etiology.

    • Patients who have already received an ICD/CRT-D for primary prevention before the admittance in the cardiac rehabilitation facility, despite a time-dependent indication to an ICD/CRT-D implantation;

    • Indication to ICD-CRT-D implantation for primary prevention.

    Exclusion Criteria:
    • Inability to give informed consent (diminished understanding or comprehension);

    • Age < 18 years;

    • NYHA Class I or IV during the cardiac rehabilitation in-hospital stay;

    • LVEF > 40% at echocardiography performed at the admittance in the cardiac rehabilitation facility

    • Absence of a time-dependent indication to an ICD/CRT-D implantation;

    • Indication to ICD-CRT-D implantation for secondary prevention.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 ICS Maugeri Pavia Italy 27100

    Sponsors and Collaborators

    • Istituti Clinici Scientifici Maugeri SpA

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Istituti Clinici Scientifici Maugeri SpA
    ClinicalTrials.gov Identifier:
    NCT05764109
    Other Study ID Numbers:
    • CE 2296
    First Posted:
    Mar 10, 2023
    Last Update Posted:
    Mar 16, 2023
    Last Verified:
    Mar 1, 2023
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Mar 16, 2023